Key facts
- Suki’s last known valuation is $295.0M (Oct 2024).
- It has raised $165.0M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Gaingels, First Round Capital, AI Venture Labs, Breyer Capital, Hedosophia — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Suki
- ·The full record, as it builds
Funding rounds
No funding rounds for Suki are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Suki
Developer of a medical voice assistant intended to streamline the process of clinical documentation and reduce the administrative burden on healthcare providers. The company's proprietary voice platform utilizes artificial intelligence and natural language processing to create detailed clinical notes during or after consultations, enabling physicians and surgeons to optimize their time, reduce burnout, and improve both the quality of patient care and the accuracy of their medical documentation.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2017
- Employees
- 397
- Website
- suki.ai/
- Ownership
- Privately Held (backing)
Suki doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Suki shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Suki in its N-PORT filings yet. We sweep new filings monthly.